CA2371928C - Neisserial vaccine compositions and methods - Google Patents

Neisserial vaccine compositions and methods Download PDF

Info

Publication number
CA2371928C
CA2371928C CA2371928A CA2371928A CA2371928C CA 2371928 C CA2371928 C CA 2371928C CA 2371928 A CA2371928 A CA 2371928A CA 2371928 A CA2371928 A CA 2371928A CA 2371928 C CA2371928 C CA 2371928C
Authority
CA
Canada
Prior art keywords
neisseria
composition
commensal
commensal neisseria
outer membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2371928A
Other languages
English (en)
French (fr)
Other versions
CA2371928A1 (en
Inventor
Andrew Robinson
Andrew Richard Gorringe
Michael John Hudson
Philippa Bracegirdle
John Simon Kroll
Keith Cartwright
Cliona Anne O'dwyer
Paul Richard Langford
Steven Anthony Rochford Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Department of Health and Social Care
Ip2ipo Innovations Ltd
Original Assignee
Department of Health and Social Care
Imperial Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9904028.9A external-priority patent/GB9904028D0/en
Priority claimed from GBGB9922561.7A external-priority patent/GB9922561D0/en
Application filed by Department of Health and Social Care, Imperial Innovations Ltd filed Critical Department of Health and Social Care
Publication of CA2371928A1 publication Critical patent/CA2371928A1/en
Application granted granted Critical
Publication of CA2371928C publication Critical patent/CA2371928C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA2371928A 1999-02-22 2000-02-22 Neisserial vaccine compositions and methods Expired - Fee Related CA2371928C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9904028.9 1999-02-22
GBGB9904028.9A GB9904028D0 (en) 1999-02-22 1999-02-22 Neisserial vaccine
GB9922561.7 1999-09-23
GBGB9922561.7A GB9922561D0 (en) 1999-09-23 1999-09-23 Neisserial vaccine compositions and methods
PCT/GB2000/000624 WO2000050074A2 (en) 1999-02-22 2000-02-22 Neisserial vaccine compositions and methods

Publications (2)

Publication Number Publication Date
CA2371928A1 CA2371928A1 (en) 2000-08-31
CA2371928C true CA2371928C (en) 2013-08-13

Family

ID=26315168

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2371928A Expired - Fee Related CA2371928C (en) 1999-02-22 2000-02-22 Neisserial vaccine compositions and methods

Country Status (12)

Country Link
US (1) US7157245B2 (enExample)
EP (2) EP1852125A3 (enExample)
JP (1) JP4982009B2 (enExample)
AT (1) ATE386541T1 (enExample)
AU (1) AU779086B2 (enExample)
CA (1) CA2371928C (enExample)
CY (1) CY1107950T1 (enExample)
DE (1) DE60038099T2 (enExample)
DK (1) DK1154791T3 (enExample)
ES (1) ES2298128T3 (enExample)
PT (1) PT1154791E (enExample)
WO (1) WO2000050074A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081244B2 (en) * 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
GB0007433D0 (en) * 2000-03-27 2000-05-17 Microbiological Res Authority Recombinant transferrin binding proteins
GB0107219D0 (en) * 2001-03-22 2001-05-16 Microbiological Res Authority Immunogenic commensal neisseria sequences
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
EP1374892A1 (en) * 2002-06-28 2004-01-02 Braun, Jan Matthias, Dr. Medicament for the treatment of diseases due to infection by Neisseria Meningitidis
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
EP1654364A4 (en) * 2003-08-13 2008-02-13 Novartis Vaccines & Diagnostic CURRENT HOST CELL RELEASE COMPRISING POLYNUCLEOTIDES ENCODING IMMUNOGENS
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
MX2010012999A (es) 2008-05-30 2012-03-07 U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB0922224D0 (en) 2009-12-21 2010-02-03 Hiltech Developments Ltd Transformation of commensal neisseria
US10900043B2 (en) 2014-09-02 2021-01-26 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating bacterial disease
WO2016036839A1 (en) * 2014-09-02 2016-03-10 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating gonorrhea
GB201522153D0 (en) 2015-12-15 2016-01-27 Univ Southampton Meningococcal infection and modified neisseria lactamica
US12005110B2 (en) 2019-02-14 2024-06-11 University Of Florida Research Foundation, Incorporated Honeybee commensal Snodgrassella alvi vaccine against pathogenic Neisseriaceae

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288617A (en) 1984-10-31 1994-02-22 Commonwealth Scientific And Industrial Research Organization Method of producing an antigenic preparation
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5470740A (en) * 1993-11-04 1995-11-28 Life Technologies, Inc. Cloned NsiI restriction-modification system
IL117483A (en) * 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
GB9811260D0 (en) * 1998-05-26 1998-07-22 Smithkline Beecham Biolog Novel compounds
GB9823978D0 (en) * 1998-11-02 1998-12-30 Microbiological Res Authority Multicomponent meningococcal vaccine
US20030215469A1 (en) * 1998-11-02 2003-11-20 Microbiological Research Authority Multicomponent meningococcal vaccine
EP1135025B1 (en) * 1998-12-02 2007-04-25 University of Maryland, Baltimore Plasmid maintenance system for antigen delivery
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
DK1154791T3 (da) * 1999-02-22 2008-06-16 Health Prot Agency Neisseria-vaccinesammensætninger og fremgangsmåder
US7081244B2 (en) * 1999-02-22 2006-07-25 Health Protection Agency Neisserial vaccine compositions and methods
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation

Also Published As

Publication number Publication date
US20030026809A1 (en) 2003-02-06
AU779086B2 (en) 2005-01-06
ES2298128T3 (es) 2008-05-16
ATE386541T1 (de) 2008-03-15
DE60038099T2 (de) 2009-02-19
JP2002537352A (ja) 2002-11-05
CY1107950T1 (el) 2013-09-04
DE60038099D1 (de) 2008-04-03
CA2371928A1 (en) 2000-08-31
PT1154791E (pt) 2008-05-30
WO2000050074A3 (en) 2000-12-28
EP1154791B1 (en) 2008-02-20
US7157245B2 (en) 2007-01-02
EP1154791A2 (en) 2001-11-21
DK1154791T3 (da) 2008-06-16
AU2681100A (en) 2000-09-14
EP1852125A3 (en) 2010-09-22
EP1852125A2 (en) 2007-11-07
WO2000050074A2 (en) 2000-08-31
JP4982009B2 (ja) 2012-07-25

Similar Documents

Publication Publication Date Title
EP1154791B1 (en) Neisserial vaccine compositions and methods
TW457247B (en) Novel antigen
US6558677B2 (en) Vaccine against gram negative bacteria
AP1027A (en) Protein K resistant surface protein of neisseria meningitidis.
CA2040544C (en) Actinobacillus pleuropneumoniae subunit vaccine
JPH04502402A (ja) 組み換えフラジエリンのワクチン
US7081244B2 (en) Neisserial vaccine compositions and methods
NO175735B (no) Fremgangsmåte ved fremstilling av Pasteurella-vaksine
HU213924B (en) Method for producing vaccine against enteric infection caused by enterotoxigenic e.coli bacteria in humans, containing formalin-killed e.coli strain having the ability of expressing colonization factor antigens
PT90310B (pt) Processo para a obtencao de preparacoes de adenilato-ciclase
Glisson et al. Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted medium
Donachie et al. Sheep antibody response to cell wall antigens expressed in vivo by Pasteurella haemolytica serotype A2
CA1331445C (en) Vaccine against e. coli septicaemia in poultry
Srivastava Immunogenicity of Pasteurella multocida grown in iron-restricted medium
CN104271733B (zh) 重组牛分枝杆菌菌株、免疫原性组合物和用途
Kharab et al. Immunogenicity of iron-regulated outer membrane proteins of Pasteurella multocida B: 2 in mice model
CA2298558A1 (en) Genetically engineered rhodococcus vaccine
JP2721218B2 (ja) ブタ赤痢ワクチン
Papezova et al. Comparison of live and inactivated Salmonella Typhimurium vaccines containing different combinations of SPI-1 and SPI-2 antigens in poultry
EP1200121B1 (en) Fish vaccine
CA2081950A1 (en) Vaccine for the prevention of infections caused by pasteurella haemolytica
Byeon et al. Generation of an attenuated Salmonella-delivery strains expressing adhesin and toxin antigens for progressive atrophic rhinitis, and evaluation of its immune responses in a murine model
Deka Comparision of iron-regulated outer membrane proteins (IrOMP) and iron-sufficient outer membrane proteins (IsOMP) of Pasteurella multocida strains of porcine origin
JP2006525373A (ja) プロテオソームを用いた感染性疾患に対する予防接種
Jaramillo-Meza et al. Challenge exposure of sheep immunized with live vaccine and culture supernatant of Mannheimia haemolytica A1: Effects of revaccination

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150223